These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24086652)

  • 21. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis.
    Stanulla M; Wang J; Chervinsky DS; Thandla S; Aplan PD
    Mol Cell Biol; 1997 Jul; 17(7):4070-9. PubMed ID: 9199342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.
    Broeker PL; Super HG; Thirman MJ; Pomykala H; Yonebayashi Y; Tanabe S; Zeleznik-Le N; Rowley JD
    Blood; 1996 Mar; 87(5):1912-22. PubMed ID: 8634439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion.
    Libura J; Slater DJ; Felix CA; Richardson C
    Blood; 2005 Mar; 105(5):2124-31. PubMed ID: 15528316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia.
    Strick R; Strissel PL; Borgers S; Smith SL; Rowley JD
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4790-5. PubMed ID: 10758153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing acute myeloid leukemia susceptibility in rearrangement-driven patients by DNA breakage at topoisomerase II and CCCTC-binding factor/cohesin binding sites.
    Atkin ND; Raimer HM; Wang Z; Zang C; Wang YH
    Genes Chromosomes Cancer; 2021 Dec; 60(12):808-821. PubMed ID: 34405474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quercetin alters the DNA damage response in human hematopoietic stem and progenitor cells via TopoII- and PI3K-dependent mechanisms synergizing in leukemogenic rearrangements.
    Biechonski S; Gourevich D; Rall M; Aqaqe N; Yassin M; Zipin-Roitman A; Trakhtenbrot L; Olender L; Raz Y; Jaffa AJ; Grisaru D; Wiesmuller L; Elad D; Milyavsky M
    Int J Cancer; 2017 Feb; 140(4):864-876. PubMed ID: 27813122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors.
    Megonigal MD; Cheung NK; Rappaport EF; Nowell PC; Wilson RB; Jones DH; Addya K; Leonard DG; Kushner BH; Williams TM; Lange BJ; Felix CA
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2814-9. PubMed ID: 10706619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cleavage of the MLL gene by activators of apoptosis is independent of topoisomerase II activity.
    Betti CJ; Villalobos MJ; Jiang Q; Cline E; Diaz MO; Loredo G; Vaughan AT
    Leukemia; 2005 Dec; 19(12):2289-95. PubMed ID: 16193084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
    Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
    Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human LPP gene is fused to MLL in a secondary acute leukemia with a t(3;11) (q28;q23).
    Dahéron L; Veinstein A; Brizard F; Drabkin H; Lacotte L; Guilhot F; Larsen CJ; Brizard A; Roche J
    Genes Chromosomes Cancer; 2001 Aug; 31(4):382-9. PubMed ID: 11433529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro cleavage of the MLL gene by topoisomerase II inhibitor (etoposide) in normal cord and peripheral blood mononuclear cells.
    Ishii E; Eguchi M; Eguchi-Ishimae M; Yoshida N; Oda M; Zaitsu M; Fujita I; Miyazaki S; Hamasaki Y; Mizutani S
    Int J Hematol; 2002 Jul; 76(1):74-9. PubMed ID: 12138900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23).
    Cerveira N; Correia C; Bizarro S; Pinto C; Lisboa S; Mariz JM; Marques M; Teixeira MR
    Oncogene; 2006 Oct; 25(45):6147-52. PubMed ID: 16682951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rearrangements involving chromosome band 11Q23 in acute leukaemia.
    Rowley JD
    Semin Cancer Biol; 1993 Dec; 4(6):377-85. PubMed ID: 8142623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.
    Rowley JD; Reshmi S; Sobulo O; Musvee T; Anastasi J; Raimondi S; Schneider NR; Barredo JC; Cantu ES; Schlegelberger B; Behm F; Doggett NA; Borrow J; Zeleznik-Le N
    Blood; 1997 Jul; 90(2):535-41. PubMed ID: 9226152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary leukemias induced by topoisomerase-targeted drugs.
    Felix CA
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):233-55. PubMed ID: 9748598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topoisomerase II and the etiology of chromosomal translocations.
    Felix CA; Kolaris CP; Osheroff N
    DNA Repair (Amst); 2006 Sep; 5(9-10):1093-108. PubMed ID: 16857431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The biological and clinical significance of MLL abnormalities in haematological malignancies.
    Mitterbauer-Hohendanner G; Mannhalter C
    Eur J Clin Invest; 2004 Aug; 34 Suppl 2():12-24. PubMed ID: 15291802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rearrangements of the MLL gene are influenced by DNA secondary structure, potentially mediated by topoisomerase II binding.
    Le H; Singh S; Shih SJ; Du N; Schnyder S; Loredo GA; Bien C; Michaelis L; Toor A; Diaz MO; Vaughan AT
    Genes Chromosomes Cancer; 2009 Sep; 48(9):806-15. PubMed ID: 19530238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukemias related to treatment with DNA topoisomerase II inhibitors.
    Felix CA
    Med Pediatr Oncol; 2001 May; 36(5):525-35. PubMed ID: 11340607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis.
    Strissel PL; Strick R; Tomek RJ; Roe BA; Rowley JD; Zeleznik-Le NJ
    Hum Mol Genet; 2000 Jul; 9(11):1671-9. PubMed ID: 10861294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.